EVATANEPAG

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C25H28N2O5S
Molecular Weight	468.565
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of EVATANEPAG

Structure Search

SMILES

CC(C)(C)C1=CC=C(CN(CC2=CC(OCC(O)=O)=CC=C2)S(=O)(=O)C3=CN=CC=C3)C=C1

InChI

InChIKey=WOHRHWDYFNWPNG-UHFFFAOYSA-N

InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29)

HIDE SMILES / InChI

Molecular Formula	C25H28N2O5S
Molecular Weight	468.565
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19250823 | https://www.ncbi.nlm.nih.gov/pubmed/14606517 | https://adisinsight.springer.com/drugs/800018231

Evatanepag (CP-533,536) is a prostaglandin E2 EP2 receptor agonist. It stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing. Evatanepag was under development with Pfizer as a bone formation stimulant for therapeutic use in the healing of fractures.

Originator

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Prostanoid EP2 receptor 19 Target ID: CHEMBL1881 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24279689	Agonist 2678		5.0 nM [EC50]

PubMed

PubMed

Title	Date	PubMed
Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.	2009 Apr 1	19250823

Patents

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:25:09 GMT 2023` Edited by `admin` on `Fri Dec 15 16:25:09 GMT 2023`
Record UNII	L266R6E31E
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

EVATANEPAG

Official Name

English

ACETIC ACID, 2-(3-((((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)(3-PYRIDINYLSULFONYL)AMINO)METHYL)PHENOXY)-

Common Name

English

2-(3-((((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)(PYRIDIN-3-YLSULFONYL)AMINO)METHYL)PHENOXY)ACETIC ACID

Systematic Name

English

Evatanepag [WHO-DD]

Common Name

English

CP-533536

Code

English

evatanepag [INN]

Common Name

English

EVATANEPAG [USAN]

Common Name

English

CP-533,536

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C78568

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

Code System Code Type Description

EPA CompTox

DTXSID20945000

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

CAS

223488-57-1

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

DRUG BANK

DB12022

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

NCI_THESAURUS

C83707

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

SMS_ID

300000034247

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

INN

9151

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

PUBCHEM

9890801

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

USAN

UU-103

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

FDA UNII

L266R6E31E

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

ChEMBL

CHEMBL563646

Created by admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023

PRIMARY

Related Record Type Details


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> SUBSTRATE


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE


					U6GMO13KCQ

EVATANEPAG SODIUM

SALT/SOLVATE -> PARENT


					805SU96HKF

CYTOCHROME P450 3A5

METABOLIC ENZYME -> SUBSTRATE


					6GS8S5F0RP

PROSTAGLANDIN E2 RECEPTOR EP2 SUBTYPE

TARGET -> AGONIST

Related Record Type Details


					598TY5TBF1

OMEGA-HYDROXY EVATANEPAG

METABOLITE -> PARENT

Comments:

IN VITRO


					YBV2AS4CUI

N-((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)-3-PYRIDINESULFONAMIDE

METABOLITE -> PARENT

Comments:

IN VITRO

C07E85AE86

N-((4-(2-HYDROXY-1,1-DIMETHYLETHYL)PHENYL)METHYL)-3-PYRIDINESULFONAMIDE

METABOLITE -> PARENT

Comments:

IN VITRO


					54SH4M23T6

DEMETHYL-HYDROXY-EVATANEPAG

METABOLITE -> PARENT

Comments:

IN VITRO


					IS7VQ3339K

PYRIDINE-N-OXIDE EVATANEPAG

METABOLITE -> PARENT

Comments:

IN VITRO


					T0I11IOI56

N-((4-(1,1-DIMETHYLETHYL)PHENYL)METHYL)-3-PYRIDINE-1-OXIDE SULFONAMIDE

METABOLITE -> PARENT

Comments:

IN VITRO


					CF591VI6I7

2-METHYL-2-(4-((PYRIDIN-3-YLSULFONYLAMINO)METHYL)PHENYL)PROPIONIC ACID

METABOLITE -> PARENT

Comments:

IN VITRO


					F8GCJ24K7V

2-(3-((((4-(1-METHYLETHENYL)PHENYL)METHYL)(3-PYRIDINYLSULFONYL)AMINO)METHYL)PHENOXY)ACETIC ACID

METABOLITE -> PARENT

Comments:

IN VITRO


					QX28NXX8UG

2-(4-(((3-CARBOXYMETHOXYBENZYL)-N-((PYRIDIN-3-YL)SULFONYL)AMINO)METHYL)PHENYL)-2-METHYLPROPIONIC ACID

METABOLITE -> PARENT

Comments:

IN VITRO


					CYE6Q281VQ

OMEGA-HYDROXY-PYRIDINE-N-OXIDE EVATANEPAG

METABOLITE -> PARENT

Comments:

IN VITRO


					4EPW47C3HA

(3-(((4-(1,1-DIMETHYL-2-OXOETHYL)BENZYL)(PYRIDIN-3-YLSULFONYL)AMINO)METHYL)PHENOXY)ACETIC ACID

METABOLITE -> PARENT

Comments:

IN VITRO


					B7PKN5HG3J

DEMETHYL-HYDROXY-OMEGA-HYDROXY EVATANEPAG

METABOLITE -> PARENT

Comments:

IN VITRO

Related Record Type Details


					L266R6E31E

ACTIVE MOIETY